Home » Theranos Withdraws FDA Emergency Clearance Request for Zika Test
Theranos Withdraws FDA Emergency Clearance Request for Zika Test
Theranos decided to rescind its request for FDA emergency clearance of its Zika nucleic acid-amplification-based assay.
The diagnostic tool, dubbed minilab, is intended to collect and process small blood samples on a compact testing platform.
The company studied the product in 16 studies across categories, including chemistry, immunochemistry, hematology and molecular biology. — José Vasquez
Upcoming Events
-
07May
-
14May
-
30May